Professor, Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Southwestern Medical School
Neurology
Dr. Elliot M. Frohman, MD
|
|
Give Review
Elliot M. Frohman works in the field of Neurology. He studied medicine at University of California Irvine School of Medicine. University of California Irvine School of Medicine is ranked 45/62 in Research/PrimaryCare. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Elliot M. Frohman is a published doctor. He published 94 publications, including: 'Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.' He accepts all Medicare patients.
Publications
- Extended interval dosing of natalizumab in Multiple sclerosis.
- B Cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses.
- Ocular motor signatures of cognitive dysfunction in Multiple sclerosis.
- A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
- Optical coherence tomography reflects Brain atrophy in MS: A four year study.
- Neuro-ophthalmic Manifestations of Cerebellar Disease.
- Retinal Damage and Vision Loss in African-American Multiple Sclerosis Patients.
- Re-evaluating the treatment of acute optic neuritis.
- The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis.
- Hiding in plain sight: a closer look at posterior cortical atrophy.
- Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis-Reply.
- Reduced spontaneous sympathetic nerve activity in Multiple sclerosis patients.
- An update on neuro-ophthalmology of multiple sclerosis: the visual System as a model to study multiple sclerosis.
- Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
- JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
- Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
- Injury to a specific neural pathway detected by Ultra-high-field MRI.
- Two demyelinating Diseases in the brain of a single patient, PML and MS: how to minimize 'one' while treating the 'other'.
- Uhthoff's phenomena in MS-clinical features and pathophysiology.
- Isolated mammillary body involvement on MRI in Wernicke's encephalopathy.
- Optic nerve head component responses of the multifocal electroretinogram in MS.
- Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric Multiple sclerosis.
- Modulation of immune function occurs within hours of therapy initiation for Multiple sclerosis.
- In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
- Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic Neuropathy.
- Expansion of CD27(high) plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.
- Interferon beta use and disability prevention in relapsing-remitting Multiple sclerosis.
- Transverse myelitis.
- Renal deterioration in Multiple sclerosis patients with neurovesical dysfunction.
- Active MS is associated with accelerated retinal ganglion Cell/inner plexiform layer thinning.
- Objective characterization of the relative afferent pupillary defect in MS.
- A Surprisingly Low Prevalence of Demonstrable Stress Urinary Incontinence and Pelvic Organ Prolapse in Women with Multiple Sclerosis Followed at a Tertiary Neurogenic ...
- Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success.
- Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased Inflammatory and reduced regulatory B cell capacity.
- WEBINO and the Return of the King's Speech.
- Optical coherence tomography segmentation reveals ganglion Cell layer pathology after optic neuritis.
- Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.
- Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion Cell layer thickness than peripapill...
- No Cerebral or Cervical Venous Insufficiency in US Veterans With Multiple Sclerosis.
- Retinal Ganglion Cell Layer Volumetric Assessment by Spectral-Domain Optical Coherence Tomography in Multiple Sclerosis: Application of a High-Precision Manual Estimat...
- One Eye or Two: A Comparison of Binocular and Monocular Low-Contrast Acuity Testing in Multiple Sclerosis.
- Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
- The impact of utilizing different optical coherence tomography devices for clinical purposes and in Multiple sclerosis trials.
- Thermoregulation in Multiple sclerosis.
- Translational research in neurology and neuroscience 2010: Multiple sclerosis.
- Clinical practice. Transverse myelitis.
- Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?
- Longitudinal study of vision and retinal nerve fiber layer thickness in Multiple sclerosis.
- Evaluating loss of visual function in Multiple sclerosis as measured by low-contrast letter acuity.
- Pearls: Multiple sclerosis.
- Macular volume determined by optical coherence tomography as a measure of neuronal loss in Multiple sclerosis.
- Depletion of B lymphocytes from Cerebral perivascular spaces by rituximab.
- Genetic polymorphism at codon 129 of the prion protein gene is not associated with Multiple sclerosis.
- Sexual dysfunction in patients with multiple sclerosis: a multiDisciplinary approach to evaluation and management.
- Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy.
- PEG minocycline-liposomes ameliorate CNS autoimmune Disease.
- Decrease in the numbers of dendritic cells and CD4+ T cells in Cerebral perivascular spaces due to natalizumab.
- Immunologic mechanisms of Multiple sclerosis.
- Reproducibility of optical coherence tomography in Multiple sclerosis.
- Impact of myelin-specific antigen presenting B Cells on T Cell activation in multiple sclerosis.
- Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in Multiple sclerosis.
- Modeling axonal degeneration within the Anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis.
- What you see is what you get: coupling function with structure in the visual System.
- Corticosteroids for multiple sclerosis: II. Application for Disease-modifying effects.
- Corticosteroids for Multiple sclerosis: I. Application for treating exacerbations.
- DNA plasmid vaccination for Multiple sclerosis.
- Humoral immune responses after rabies infection.
- High incidence of post-lumbar puncture Headaches in patients with multiple sclerosis treated with natalizumab: role of intrathecal leukocytes.
- Is neuromyelitis optica distinct from Multiple sclerosis?: something for "lumpers" and "splitters".
- W. Ian McDonald, MB, ChB, PhD (1933-2006): the Multiple sclerosis physician-scientist of the 20th century.
- Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions.
- Altered CD4+/CD8+ T-Cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
- Immune surveillance in Multiple sclerosis patients treated with natalizumab.
- Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to Multiple sclerosis.
- Diagnosis and management of Multiple sclerosis: case studies.
- Multiple sclerosis--the plaque and its pathogenesis.
- Overdiagnosis of Multiple sclerosis by magnetic resonance imaging.
- Relation of visual function to retinal nerve fiber layer thickness in Multiple sclerosis.
- Sympathomimetic-induced kaleidoscopic visual illusion associated with a reversible splenium lesion.
- Therapeutic considerations for Disease progression in multiple sclerosis: evidence, experience, and future expectations.
- Effect of rituximab on the peripheral blood and cerebrospinal fluid B Cells in patients with primary progressive multiple sclerosis.
- Isolated relative afferent pupillary defect secondary to contralateral midBrain compression.
- Spinal neurosarcoidosis mimicking an idiopathic inflammatory demyelinating Syndrome.
- Mycophenolate mofetil in Multiple sclerosis.
- Fatigue in Multiple sclerosis: is the picture getting simpler or more complex?
- Disease-modifying Therapies for Multiple Sclerosis.
- Acquired sexual paraphilia in patients with Multiple sclerosis.
- Sexual dysfunction in neurologic Disease.
- The effects of horizontal head position (yaw axis) and step velocity on the vestibulo-ocular reflex.
- Glatiramer acetate (Copaxone) therapy induces CD8(+) T Cell responses in patients with multiple sclerosis.
- Bladder, Bowel, and Sexual Dysfunction in Multiple Sclerosis.
- Changes in JC virus-specific T Cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.
- Retinal thickness measured with optical coherence tomography and risk of disability worsening in Multiple sclerosis: a cohort study.
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- Bell's Palsy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Johns Hopkins University -
University of California Irvine School of Medicine
Hospital
-
University of Texas Southwestern Medical Center -
Children's Health System of Texas -
Parkland Health & Hospital System
Drug Facts
| NPI NUMBER | 1689630147 | |
| NPPES Provider LastName | FROHMAN | |
| NPPES Provider FirstName | ELLIOT | |
| NPPES Provider ZIPCode | 753907208 | |
| NPPES Provider State | TX | |
| Specialty Description | Neurology | |
| Total Claim Count | 3113.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 85.0 | |
| Percent Opioid Claims | 2.73 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689630147 |
| Last Name Of The Provider | FROHMAN |
| First Name Of The Provider | ELLIOT |
| View All |
Similar Doctors
|
|
Dr. Norma B. Melamed, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan T. Arnold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gil I. Wolfe, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Venkatesh N. Nagaraddi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kyle B. Womack, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph T. Phillips Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Audrey Stein-Goldings, MD |
|
|
Dr. Richard B. Dewey Jr., MD |
|
|
Dr. Rexford K. Anderson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Afsaneh Shirani, MD
This Doctor is OpenDoctor Recommended.
|